77 related articles for article (PubMed ID: 14612491)
1. Identification of COX17 as a therapeutic target for non-small cell lung cancer.
Suzuki C; Daigo Y; Kikuchi T; Katagiri T; Nakamura Y
Cancer Res; 2003 Nov; 63(21):7038-41. PubMed ID: 14612491
[TBL] [Abstract][Full Text] [Related]
2. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Furukawa C; Daigo Y; Ishikawa N; Kato T; Ito T; Tsuchiya E; Sone S; Nakamura Y
Cancer Res; 2005 Aug; 65(16):7102-10. PubMed ID: 16103059
[TBL] [Abstract][Full Text] [Related]
3. Identification of RAI3 as a therapeutic target for breast cancer.
Nagahata T; Sato T; Tomura A; Onda M; Nishikawa K; Emi M
Endocr Relat Cancer; 2005 Mar; 12(1):65-73. PubMed ID: 15788639
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
[TBL] [Abstract][Full Text] [Related]
5. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
Takahashi K; Furukawa C; Takano A; Ishikawa N; Kato T; Hayama S; Suzuki C; Yasui W; Inai K; Sone S; Ito T; Nishimura H; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2006 Oct; 66(19):9408-19. PubMed ID: 17018595
[TBL] [Abstract][Full Text] [Related]
6. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
[TBL] [Abstract][Full Text] [Related]
7. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis.
Kato T; Daigo Y; Hayama S; Ishikawa N; Yamabuki T; Ito T; Miyamoto M; Kondo S; Nakamura Y
Cancer Res; 2005 Jul; 65(13):5638-46. PubMed ID: 15994936
[TBL] [Abstract][Full Text] [Related]
8. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
[TBL] [Abstract][Full Text] [Related]
11. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
[TBL] [Abstract][Full Text] [Related]
13. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
Kanai R; Eguchi K; Takahashi M; Goldman S; Okano H; Kawase T; Yazaki T
J Gene Med; 2006 Nov; 8(11):1329-40. PubMed ID: 16955534
[TBL] [Abstract][Full Text] [Related]
14. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
16. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
17. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers.
Mijatovic T; Roland I; Van Quaquebeke E; Nilsson B; Mathieu A; Van Vynckt F; Darro F; Blanco G; Facchini V; Kiss R
J Pathol; 2007 Jun; 212(2):170-9. PubMed ID: 17471453
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel putative non-coding RNA involved in proliferation arrest of a non-small cell lung carcinoma cell line treated with an original chemical substance, methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate.
Jacquot C; Carbonnelle D; Tomasoni C; Papaconstadinou A; Roussis V; Roussakis C
Int J Oncol; 2004 Aug; 25(2):519-27. PubMed ID: 15254752
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
[TBL] [Abstract][Full Text] [Related]
20. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]